PHILADELPHIA, Oct. 23, 2008 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) noted today that a member of its Scientific Advisory Board, Prof. Luc Montagnier, a winner of the 2008 Nobel Prize in Physiology and Medicine, confirms the importance of adjuvants in a current article in the Wall Street Journal (Oct. 21, 2008, p.A19). In his article entitled "The Next Steps to Take in Beating AIDS", Prof. Montagnier, indicates that "after partial restoration (...of the patient's immune system) by an antiretroviral treatment...at the same time the immune system should be fully restored with proper adjuvants."
